News | Artificial Intelligence | June 08, 2020

Lunit's AI Solution for COVID-19 has Users in Over 10 Countries

With users for clinical and trial in countries such as Italy, France, Portugal, Brazil, Indonesia, Panama, South Korea, etc., Lunit seeks to become a worldwide provider of AI solution in COVID-19 management

Lunit announced that their AI solution for chest x-ray analysis is now being used and tested in more than 10 countries for COVID-19 management, providing assistance in chest X-ray interpretation during patient triage and monitoring.

A radiologist in Hospital do Câncer de Pernambuco, located in Recife, Brazil, is examining a chest x-ray image using Lunit INSIGHT CXR.

Radiologists at Indonesia RSCM discusses after seeing analysis results provided by Lunit INSIGHT CXR.

Radiologists at Indonesia RSCM discusses after seeing analysis results provided by Lunit INSIGHT CXR.

June 8, 2020 — Lunit announced that their AI solution for chest x-ray analysis is now being used and tested in more than 10 countries for COVID-19 management, providing assistance in chest X-ray interpretation during patient triage and monitoring.

The firm had released the AI solution in late March, providing the algorithm online to help healthcare providers manage COVID-19. Since then, the firm had deployed its software onsite in more than 10 locations throughout different countries, including Italy, France, Portugal, Brazil, Indonesia, Panama and South Korea.

“Together with our partners, we took a step further from providing the solution online, now actively deploying the AI on-site within the hospitals,” said Brandon Suh, CEO of Lunit. “The actual use of AI within COVID-19 management varies on the independent hospital systems and workflow, but generally the software provides assistance in the interpretation of chest x-ray images during triaging symptomatic patients and monitoring admitted patients with COVID-19.”

Lunit is in partnership with Vizyon, a French teleradiology firm that specializes in providing a platform for AI software by connecting the technology to hospitals. Vizyon is using Lunit AI in analyzing the images they receive from their clients.

“During patient triage, Lunit INSIGHT CXR developed for COVID-19 can accelerate the decision-making of patients with symptoms while awaiting PCR results,” said Pierre Durand, M.D., of Vizyon. When the symptomatic patient shows up to a hospital, the patient is tested with both PCR and AI-assisted chest x-ray, with the latter providing an analysis result in less than 5 minutes. 

“The doctor, upon reviewing the analysis made by AI, can promptly decide whether to send the patient back home or to the Emergency Hospital, depending on the severity. PCR results generally take six to 24 hours, risking a longer window of contamination while awaiting results, a longer gap of treatment, and a possible hospital overload,” Durand added.

Brazil was one of the early adopters of the solution, installed and tested at more than 11 hospitals including PreventSenior, one of the largest hospital networks in Brazil with 8 locations throughout the metropolitan region of Sao Paulo. Now having analyzed more than 30,000 chest x-ray images of COVID-19 cases in the last two months, a physician at PreventSenior said that “Lunit INSIGHT CXR seems to provide great help, especially for patient triage,” as the hospital is overflowing with patients while the number of radiologists remains limited.

In Italy, a country that saw large numbers of COVID-19 cases, Lunit AI is being used in Vimercate hospital, deployed through the company’s partnership with Fujifilm. The COVID-19 crisis has brought a need to improve workflow in the hospital, by easing the burden of reading a mass amount of exams. The hospital is based in Lombardia, Italy, and takes around 160,000 radiology exams in a year with 17 radiologists and 19 technicians. 

AI findings are integrated into the Fujifilm Synapse platform which Vimercate hospital uses for reading radiologic images. According to the hospital, Lunit INSIGHT is used for every chest x-ray analysis, including emergency room patients with respiratory symptoms and patients with COVID-19. It is also used to examine a discharging patient with no symptoms, and to evaluate the feasibility of anesthesia prior to a surgical operation.

The original algorithm of Lunit INSIGHT CXR detects 10 findings from chest x-ray images including consolidation, nodule, pneumothorax, and more. It is CE marked and clinically available in Europe. 

“Among the many hospitals we have been in touch with, many of them were experiencing frustrations from limited PCR tests and/or a lack of manpower and resources,” said Minhong Jang, Chief Business Officer at Lunit. “In hopes of sharing the burden, we are seeking more health facilities where we can provide assistance with advanced technology. We welcome you to learn more about our solution and reach out to better manage the current crisis."

For more information: www.lunit.io

Related Content

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

News | Artificial Intelligence | May 07, 2021
3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

News | Magnetic Resonance Imaging (MRI) | May 06, 2021
May 6, 2021 — Magnetic Resonance Imaging
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by

After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by N. Galldiks et al., Research Center Juelich, Juelich, Germany.

News | PET Imaging | May 05, 2021
May 5, 2021 — For patients with brain metastases, amino acid ...
When working with a vendor on project implementation, it is critical to focus on the actual execution of the implementation

Getty Images

Feature | Radiology Business | May 05, 2021 | By Jef Williams
You have selected a vendor. Congratulations.